Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Study - OPTIMAL - Rituximab 375 / high dose Methotrexate 3000, diffuse large B-non-Hodgkin Lymphoma, CNS Prophylaxis

Protocol-ID: 1133 V1.0 (Mini), STUDY OPTIMAL - RITU375/HDMTRX3000, DLBCL, CNS Prophylaxis
Study protocol, available to authorized participants only.

Indication(s)

  • Malignant Meningitis (Lymphomatous Meningitis); ICD-10 C79.3
  • NHL, B-Cell Type, Diffuse Large Cell; ICD-10 C83.3
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 19.06.2018